ISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)

MANUFACTURER: Glentek

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Therapeutic Goods Administration (TGA)

Medicines & Healthcare products Regulatory Agency (MHRA)

The Medicines Evaluation Board (MEB)

Riluzole is a medication that has been approved by the US FDA for the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurological disorder.